levodopa and sl 327
levodopa has been researched along with sl 327 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
| Britt, JP; Ding, Y; Kang, UJ; Lim, SA; McGehee, DS; Won, L | 1 |
Other Studies
2 other study(ies) available for levodopa and sl 327
| Article | Year |
|---|---|
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |
Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice.
Topics: Adenosine A2 Receptor Antagonists; Aminoacetonitrile; Animals; Aphakia; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Dopamine; Dyskinesias; Gene Expression Regulation; Homeodomain Proteins; Levodopa; Mice; Mice, Transgenic; Neurons; Parkinson Disease; Phosphorylation; Transcription Factors | 2011 |